NCT00411450 Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment Status COMPLETED Phase PHASE2
NCT00352950 Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer Status WITHDRAWN Phase PHASE1
NCT00283439 A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00091806 Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1